Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis

Background Meta‐analysis can identify biological factors that moderate cardiac magnetic resonance myocardial tissue markers such as native T1 (longitudinal magnetization relaxation time constant) and T2 (transverse magnetization relaxation time constant) in cohorts recovering from COVID‐19 infection...

Full description

Bibliographic Details
Main Authors: Michael Jerosch‐Herold, Carsten Rickers, Steffen E. Petersen, Otávio R. Coelho‐Filho
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027801
_version_ 1797866364078129152
author Michael Jerosch‐Herold
Carsten Rickers
Steffen E. Petersen
Otávio R. Coelho‐Filho
author_facet Michael Jerosch‐Herold
Carsten Rickers
Steffen E. Petersen
Otávio R. Coelho‐Filho
author_sort Michael Jerosch‐Herold
collection DOAJ
description Background Meta‐analysis can identify biological factors that moderate cardiac magnetic resonance myocardial tissue markers such as native T1 (longitudinal magnetization relaxation time constant) and T2 (transverse magnetization relaxation time constant) in cohorts recovering from COVID‐19 infection. Methods and Results Cardiac magnetic resonance studies of patients with COVID‐19 using myocardial T1, T2 mapping, extracellular volume, and late gadolinium enhancement were identified by database searches. Pooled effect sizes and interstudy heterogeneity (I2) were estimated with random effects models. Moderators of interstudy heterogeneity were analyzed by meta‐regression of the percent difference of native T1 and T2 between COVID‐19 and control groups (%ΔT1 [percent difference of the study‐level means of myocardial T1 in patients with COVID‐19 and controls] and %ΔT2 [percent difference of the study‐level means of myocardial T2 in patients with COVID‐19 and controls]), extracellular volume, and the proportion of late gadolinium enhancement. Interstudy heterogeneities of %ΔT1 (I2=76%) and %ΔT2 (I2=88%) were significantly lower than for native T1 and T2, respectively, independent of field strength, with pooled effect sizes of %ΔT1=1.24% (95% CI, 0.54%–1.9%) and %ΔT2=3.77% (95% CI, 1.79%–5.79%). %ΔT1 was lower for studies in children (median age: 12.7 years) and athletes (median age: 21 years), compared with older adults (median age: 48 years). Duration of recovery from COVID‐19, cardiac troponins, C‐reactive protein, and age were significant moderators for %ΔT1 and/or %ΔT2. Extracellular volume, adjusted by age, was moderated by recovery duration. Age, diabetes, and hypertension were significant moderators of the proportion of late gadolinium enhancement in adults. Conclusions T1 and T2 are dynamic markers of cardiac involvement in COVID‐19 that reflect the regression of cardiomyocyte injury and myocardial inflammation during recovery. Late gadolinium enhancement and to a lesser extent extracellular volume, are more static biomarkers moderated by preexisting risk factors linked to adverse myocardial tissue remodeling.
first_indexed 2024-04-09T23:22:59Z
format Article
id doaj.art-694deb03bf904b4fa211f5acef9308c5
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-09T23:22:59Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-694deb03bf904b4fa211f5acef9308c52023-03-21T11:45:26ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-03-0112610.1161/JAHA.122.027801Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐AnalysisMichael Jerosch‐Herold0Carsten Rickers1Steffen E. Petersen2Otávio R. Coelho‐Filho3Department of Radiology, Cardiovascular Imaging Section Brigham and Women’s Hospital Boston MAChildren’s Heart Clinic, Adult Congenital Heart Disease Section University Hospital Hamburg‐Eppendorf (UKE) Hamburg GermanyWilliam Harvey Research Institute NIHR Barts Biomedical Research Centre, Queen Mary University London, Charterhouse Square London United KingdomDepartment of Internal Medicine State University of Campinas (UNICAMP) Campinas, São Paulo BrazilBackground Meta‐analysis can identify biological factors that moderate cardiac magnetic resonance myocardial tissue markers such as native T1 (longitudinal magnetization relaxation time constant) and T2 (transverse magnetization relaxation time constant) in cohorts recovering from COVID‐19 infection. Methods and Results Cardiac magnetic resonance studies of patients with COVID‐19 using myocardial T1, T2 mapping, extracellular volume, and late gadolinium enhancement were identified by database searches. Pooled effect sizes and interstudy heterogeneity (I2) were estimated with random effects models. Moderators of interstudy heterogeneity were analyzed by meta‐regression of the percent difference of native T1 and T2 between COVID‐19 and control groups (%ΔT1 [percent difference of the study‐level means of myocardial T1 in patients with COVID‐19 and controls] and %ΔT2 [percent difference of the study‐level means of myocardial T2 in patients with COVID‐19 and controls]), extracellular volume, and the proportion of late gadolinium enhancement. Interstudy heterogeneities of %ΔT1 (I2=76%) and %ΔT2 (I2=88%) were significantly lower than for native T1 and T2, respectively, independent of field strength, with pooled effect sizes of %ΔT1=1.24% (95% CI, 0.54%–1.9%) and %ΔT2=3.77% (95% CI, 1.79%–5.79%). %ΔT1 was lower for studies in children (median age: 12.7 years) and athletes (median age: 21 years), compared with older adults (median age: 48 years). Duration of recovery from COVID‐19, cardiac troponins, C‐reactive protein, and age were significant moderators for %ΔT1 and/or %ΔT2. Extracellular volume, adjusted by age, was moderated by recovery duration. Age, diabetes, and hypertension were significant moderators of the proportion of late gadolinium enhancement in adults. Conclusions T1 and T2 are dynamic markers of cardiac involvement in COVID‐19 that reflect the regression of cardiomyocyte injury and myocardial inflammation during recovery. Late gadolinium enhancement and to a lesser extent extracellular volume, are more static biomarkers moderated by preexisting risk factors linked to adverse myocardial tissue remodeling.https://www.ahajournals.org/doi/10.1161/JAHA.122.027801cardiac magnetic resonanceCOVID‐19extracellular volumelate gadolinium enhancementmeta‐analysisT1‐mapping
spellingShingle Michael Jerosch‐Herold
Carsten Rickers
Steffen E. Petersen
Otávio R. Coelho‐Filho
Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiac magnetic resonance
COVID‐19
extracellular volume
late gadolinium enhancement
meta‐analysis
T1‐mapping
title Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
title_full Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
title_fullStr Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
title_full_unstemmed Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
title_short Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID‐19: A Meta‐Analysis
title_sort myocardial tissue characterization in cardiac magnetic resonance studies of patients recovering from covid 19 a meta analysis
topic cardiac magnetic resonance
COVID‐19
extracellular volume
late gadolinium enhancement
meta‐analysis
T1‐mapping
url https://www.ahajournals.org/doi/10.1161/JAHA.122.027801
work_keys_str_mv AT michaeljeroschherold myocardialtissuecharacterizationincardiacmagneticresonancestudiesofpatientsrecoveringfromcovid19ametaanalysis
AT carstenrickers myocardialtissuecharacterizationincardiacmagneticresonancestudiesofpatientsrecoveringfromcovid19ametaanalysis
AT steffenepetersen myocardialtissuecharacterizationincardiacmagneticresonancestudiesofpatientsrecoveringfromcovid19ametaanalysis
AT otaviorcoelhofilho myocardialtissuecharacterizationincardiacmagneticresonancestudiesofpatientsrecoveringfromcovid19ametaanalysis